Review Note

Last Update: 01/24/2025 08:27 AM

Current Deck: Geneeskunde::3e bachelor::Nier en spijs::ZSO 32: Nierfarmacologie::Shanna's Snelweg naar Succes

New Card (Unpublished)

Currently Published Content


Question
Title
QType (0=kprim,1=mc,2=sc)
Q_1
Q_2
Q_3
Q_4
Q_5
Answers
Sources
Extra 1

No published tags.

Pending Suggestions


Field Change Suggestions:
Although the patient's disease was adequately controlled with an NSAID and rnethotrexate for some time, her symptoms began to worsen and radiologic studies of her hands indicated progressive destruction in the joints of several fingers. Treat ment with another second-line agent for rheumatoid arthri tis was considered. Which of the following is a parenterally administered DMARD whose mechanism of anti-inflamma tory action is antagonism of tumor necrosis factor?
A 54-year-old woman presented with signs and symptoms consistent with an early stage of rheumatoid arthri tis. The decision was made to initiate NSAID therapy.
QType (0=kprim,1=mc,2=sc)
Commit #268356
2
(A) Anakinra
(B) Abatacept
(C) Etanercept
(D) Penicillamine
(E) Sulfasalazine
0 0 1 0 0
Katzung
Etanercept is a recombinant protein that binds to tumor necrosis factor and prevents its inflammatory effects. The answer is C.